Apyx Medical (APYX) Current Assets (2010 - 2026)

Apyx Medical has reported Current Assets for 17 years, with the latest figure at $54.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 5.68% year-over-year to $54.8 million; the trailing twelve-month figure through Mar 2026 stood at $54.8 million (up 5.68% YoY), and the FY2025 full-year result was $58.5 million, up 3.6% from the prior year.
• Current Assets for Q1 2026 stood at $54.8 million, down from $58.5 million in the prior quarter.
• The five-year high for Current Assets was $70.4 million in Q4 2023, with the low at $43.0 million in Q4 2022.
• Historically, Current Assets has averaged $53.6 million across 5 years, with a median of $52.7 million in 2023.
• Annual changes were most pronounced in 2022 — Current Assets declined 29.25% — and 2023, when it surged 63.74%.
• Apyx Medical's Current Assets stood at $43.0 million in 2022, then surged by 63.74% to $70.4 million in 2023, then declined by 19.79% to $56.4 million in 2024, then increased by 3.6% to $58.5 million in 2025, then decreased by 6.29% to $54.8 million in 2026.
• The last three Current Assets figures came in at $54.8 million (Q1 2026), $58.5 million (Q4 2025), and $48.8 million (Q3 2025), per Business Quant data.